Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (419 total)
-
Creator: Farhad Memarzadeh, ASHE-FGI monograph
Subject: Physical Infrastructure
Item Type: Publication
Date Last Updated: 2013
Description: Current recommended ventilation rates for health care facilities are not always based on hard data, but on experience. In this joint ASHE-FGI monograph, Farhad Memarzadeh, PhD, PE, looks at research on hospitals, schools, aircraft, and other vehicles…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Creator: Fausther-Bovendo, Hugues, and Gary Kobinger.
Subject: Laboratory
Item Type: Publication
Date Last Updated: 2020-11-17
Description: The 2013–16 Ebola virus outbreak—the largest ever recorded—substantially hastened the development of an Ebola virus vaccine. Before this outbreak, the safety and immunogenicity of only two Ebola virus vaccine candidates (a DNA-based vaccine and a…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Creator: FDA
Subject: Research
Item Type: Hyperlink
Date Last Updated: 2021-05
Description: Guidance for Sponsors, Clinical Investigators, and IRBs. Information for investigational new drugs (IND).
Draft Information Sheet Guidance for Sponsors, Clinical Investigators, and IRBs Frequently Asked Questions Statement of Investigator (Form FDA… -
Creator: FDA
Subject: Research
Item Type: Hyperlink
Date Last Updated: 2022-07-20
Description: Current Federal law requires that a drug be the subject of an approved marketing application before it is transported or distributed across state lines. Because a sponsor will probably want to ship the investigational drug to clinical investigators… -
Creator: FDA
Subject: Research
Item Type: Hyperlink
Date Last Updated: 2023-05-12
Description: The Emergency Use Authorization (EUA) authority allows FDA to help strengthen the nation’s public health protections against chemical, biological, radiological, and nuclear (CBRN) threats including infectious diseases, by facilitating the… -
Creator: Feistritzer, N. R., C. Hill, S. Vanairsdale, and J. Gentry
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2014-11
Description: Caring for patients with Ebola virus disease requires strict biosafety protocols to eliminate exposure and ensure containment. Training and competency verification were critical to creation of a safe environment for nursing staff involved in the… -
Creator: Feldmann, Heinz, Armand Sprecher, and Thomas W. Geisbert.
Subject: General
Item Type: Publication
Date Last Updated: 2020-05-07
Description: Ebola virus (EBOV) was the best-known and most extensively studied member of the Filoviridae family (Mononegavirales order) long before the shattering 2013–2016 West African epidemic. The virologic taxon Filoviridae was defined in 1982 and… -
Creator: Ferranti, E. P., L. Wands, K. A. Yeager, B. Baker, M. K. Higgins, J. L. Wold and S. B. Dunbar
Subject: Training and Exercises
Item Type: Publication
Date Last Updated: 2018-01-08
Description: Implementation of an educational program for nursing students amidst the Ebola virus disease epidemic -
Creator: Fink, Sheri L.
Subject: Emergency Management
Item Type: Publication
Date Last Updated: 2010
Description: Demand for critical care resources could vastly outstrip supply in an influenza pandemic or other health emergency, which has led expert groups to propose altered standards for triage and resource allocation. -
Creator: Fischer, W. A. N., P. Vetter, D. G. Bausch, T. Burgess, R. T. Davey, Jr., R. Fowler, F. G. Hayden, P. B. Jahrling, A. C. Kalil, D. L. Mayers, A. K. Mehta, T. M. Uyeki and M. Jacobs
Subject: Research
Item Type: Publication
Date Last Updated: 2017-11-15
Description: The massive outbreak of Ebola virus disease in west Africa between 2013 and 2016 resulted in intense efforts to evaluate the efficacy of several specific countermeasures developed through years of preclinical work, including the first clinical trials…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
